 | • レポートコード：D0GIR-02072 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、PCR腸疾患検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。PCR腸疾患検査の種類別市場規模（アナライザー/機器、キット/パネル）、用途別市場規模（クロストリジウムディフィシル、カンピロバクテリア症、コレラ、大腸菌感染症、ピロリ菌感染症、サルモネラ症、赤痢、ロタウイルス感染症、ノロウイルス感染症、寄生虫性腸疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific、Trinity Biotech、Meridian Life Science、Vela Diagnostics、bioMerieux SA、CorisBioconcept、Etta Healthcare (Ovagene Oncology)、Abbott (ALERE)、Bio-Rad Laboratories、DiaSorin Molecular、Fluxergy、Genalyte、ExcitePCR (PositiveID Corporation)、GenSpeed Biotech、Focus Diagnostics (DiaSorin Molecular)、FluimediX、Flow Alliance、GeneFluidics、Future Horizon Scientific、Fluid-Screen、iLine Microsystems、Gulf Bio Analytical、IDEX Health&Science、Danaher、HemoCue、Hahn-Schickard、Inflammatix、Helvoet ・地域別グローバル市場分析 2015年-2020年 ・PCR腸疾患検査の北米市場（アメリカ、カナダ、メキシコ） ・PCR腸疾患検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・PCR腸疾患検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・PCR腸疾患検査の南米市場（ブラジル、アルゼンチン） ・PCR腸疾患検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：アナライザー/機器、キット/パネル ・用途別分析：クロストリジウムディフィシル、カンピロバクテリア症、コレラ、大腸菌感染症、ピロリ菌感染症、サルモネラ症、赤痢、ロタウイルス感染症、ノロウイルス感染症、寄生虫性腸疾患 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The PCR-based Enteric Disease Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global PCR-based Enteric Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
PCR-based Enteric Disease Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, PCR-based Enteric Disease Testing market has been segmented into:
Analyzers/Instruments
Kits/Panels
By Application, PCR-based Enteric Disease Testing has been segmented into:
Clostridium Difficile
Campylobacteriosis
Cholera
E. coli Infection
H. pylori Infection
Salmonellosis
Shigellosis
Rotavirus Infection
Norovirus Infection
Parasitic Enteric Disease
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global PCR-based Enteric Disease Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level PCR-based Enteric Disease Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global PCR-based Enteric Disease Testing market.
The report offers in-depth assessment of the growth and other aspects of the PCR-based Enteric Disease Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and PCR-based Enteric Disease Testing Market Share Analysis
PCR-based Enteric Disease Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, PCR-based Enteric Disease Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the PCR-based Enteric Disease Testing sales, revenue and market share for each player covered in this report.
The major players covered in PCR-based Enteric Disease Testing are:
Thermo Fisher Scientific
Trinity Biotech
Meridian Life Science
Vela Diagnostics
bioMerieux SA
CorisBioconcept
Etta Healthcare (Ovagene Oncology)
Abbott (ALERE)
Bio-Rad Laboratories
DiaSorin Molecular
Fluxergy
Genalyte
ExcitePCR (PositiveID Corporation)
GenSpeed Biotech
Focus Diagnostics (DiaSorin Molecular)
FluimediX
Flow Alliance
GeneFluidics
Future Horizon Scientific
Fluid-Screen
iLine Microsystems
Gulf Bio Analytical
IDEX Health&Science
Danaher
HemoCue
Hahn-Schickard
Inflammatix
Helvoet
Among other players domestic and global, PCR-based Enteric Disease Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 PCR-based Enteric Disease Testing Market Overview
1.1 Product Overview and Scope of PCR-based Enteric Disease Testing
1.2 Classification of PCR-based Enteric Disease Testing by Type
1.2.1 Global PCR-based Enteric Disease Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global PCR-based Enteric Disease Testing Revenue Market Share by Type in 2019
1.2.3 Analyzers/Instruments
1.2.4 Kits/Panels
1.3 Global PCR-based Enteric Disease Testing Market by Application
1.3.1 Overview: Global PCR-based Enteric Disease Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clostridium Difficile
1.3.3 Campylobacteriosis
1.3.4 Cholera
1.3.5 E. coli Infection
1.3.6 H. pylori Infection
1.3.7 Salmonellosis
1.3.8 Shigellosis
1.3.9 Rotavirus Infection
1.3.10 Norovirus Infection
1.3.11 Parasitic Enteric Disease
1.4 Global PCR-based Enteric Disease Testing Market by Regions
1.4.1 Global PCR-based Enteric Disease Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of PCR-based Enteric Disease Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) PCR-based Enteric Disease Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) PCR-based Enteric Disease Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) PCR-based Enteric Disease Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) PCR-based Enteric Disease Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) PCR-based Enteric Disease Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Trinity Biotech
2.2.1 Trinity Biotech Details
2.2.2 Trinity Biotech Major Business
2.2.3 Trinity Biotech SWOT Analysis
2.2.4 Trinity Biotech Product and Services
2.2.5 Trinity Biotech PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Meridian Life Science
2.3.1 Meridian Life Science Details
2.3.2 Meridian Life Science Major Business
2.3.3 Meridian Life Science SWOT Analysis
2.3.4 Meridian Life Science Product and Services
2.3.5 Meridian Life Science PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Vela Diagnostics
2.4.1 Vela Diagnostics Details
2.4.2 Vela Diagnostics Major Business
2.4.3 Vela Diagnostics SWOT Analysis
2.4.4 Vela Diagnostics Product and Services
2.4.5 Vela Diagnostics PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 bioMerieux SA
2.5.1 bioMerieux SA Details
2.5.2 bioMerieux SA Major Business
2.5.3 bioMerieux SA SWOT Analysis
2.5.4 bioMerieux SA Product and Services
2.5.5 bioMerieux SA PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 CorisBioconcept
2.6.1 CorisBioconcept Details
2.6.2 CorisBioconcept Major Business
2.6.3 CorisBioconcept Product and Services
2.6.4 CorisBioconcept PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Etta Healthcare (Ovagene Oncology)
2.7.1 Etta Healthcare (Ovagene Oncology) Details
2.7.2 Etta Healthcare (Ovagene Oncology) Major Business
2.7.3 Etta Healthcare (Ovagene Oncology) Product and Services
2.7.4 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abbott (ALERE)
2.8.1 Abbott (ALERE) Details
2.8.2 Abbott (ALERE) Major Business
2.8.3 Abbott (ALERE) Product and Services
2.8.4 Abbott (ALERE) PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bio-Rad Laboratories
2.9.1 Bio-Rad Laboratories Details
2.9.2 Bio-Rad Laboratories Major Business
2.9.3 Bio-Rad Laboratories Product and Services
2.9.4 Bio-Rad Laboratories PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 DiaSorin Molecular
2.10.1 DiaSorin Molecular Details
2.10.2 DiaSorin Molecular Major Business
2.10.3 DiaSorin Molecular Product and Services
2.10.4 DiaSorin Molecular PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Fluxergy
2.11.1 Fluxergy Details
2.11.2 Fluxergy Major Business
2.11.3 Fluxergy Product and Services
2.11.4 Fluxergy PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.12 Genalyte
2.12.1 Genalyte Details
2.12.2 Genalyte Major Business
2.12.3 Genalyte Product and Services
2.12.4 Genalyte PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.13 ExcitePCR (PositiveID Corporation)
2.13.1 ExcitePCR (PositiveID Corporation) Details
2.13.2 ExcitePCR (PositiveID Corporation) Major Business
2.13.3 ExcitePCR (PositiveID Corporation) Product and Services
2.13.4 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.14 GenSpeed Biotech
2.14.1 GenSpeed Biotech Details
2.14.2 GenSpeed Biotech Major Business
2.14.3 GenSpeed Biotech Product and Services
2.14.4 GenSpeed Biotech PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.15 Focus Diagnostics (DiaSorin Molecular)
2.15.1 Focus Diagnostics (DiaSorin Molecular) Details
2.15.2 Focus Diagnostics (DiaSorin Molecular) Major Business
2.15.3 Focus Diagnostics (DiaSorin Molecular) Product and Services
2.15.4 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.16 FluimediX
2.16.1 FluimediX Details
2.16.2 FluimediX Major Business
2.16.3 FluimediX Product and Services
2.16.4 FluimediX PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.17 Flow Alliance
2.17.1 Flow Alliance Details
2.17.2 Flow Alliance Major Business
2.17.3 Flow Alliance Product and Services
2.17.4 Flow Alliance PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.18 GeneFluidics
2.18.1 GeneFluidics Details
2.18.2 GeneFluidics Major Business
2.18.3 GeneFluidics Product and Services
2.18.3 GeneFluidics PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.19 Future Horizon Scientific
2.19.1 Future Horizon Scientific Details
2.19.2 Future Horizon Scientific Major Business
2.19.3 Future Horizon Scientific Product and Services
2.19.4 Future Horizon Scientific PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.20 Fluid-Screen
2.20.1 Fluid-Screen Details
2.20.2 Fluid-Screen Major Business
2.20.3 Fluid-Screen Product and Services
2.20.4 Fluid-Screen PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.21 iLine Microsystems
2.21.1 iLine Microsystems Details
2.21.2 iLine Microsystems Major Business
2.21.3 iLine Microsystems Product and Services
2.21.4 iLine Microsystems PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.22 Gulf Bio Analytical
2.22.1 Gulf Bio Analytical Details
2.22.2 Gulf Bio Analytical Major Business
2.22.3 Gulf Bio Analytical Product and Services
2.22.4 Gulf Bio Analytical PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.23 IDEX Health&Science
2.23.1 IDEX Health&Science Details
2.23.2 IDEX Health&Science Major Business
2.23.3 IDEX Health&Science Product and Services
2.23.4 IDEX Health&Science PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.24 Danaher
2.24.1 Danaher Details
2.24.2 Danaher Major Business
2.24.3 Danaher Product and Services
2.24.4 Danaher PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.25 HemoCue
2.25.1 HemoCue Details
2.25.2 HemoCue Major Business
2.25.3 HemoCue Product and Services
2.25.4 HemoCue PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.26 Hahn-Schickard
2.26.1 Hahn-Schickard Details
2.26.2 Hahn-Schickard Major Business
2.26.3 Hahn-Schickard Product and Services
2.26.4 Hahn-Schickard PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.27 Inflammatix
2.27.1 Inflammatix Details
2.27.2 Inflammatix Major Business
2.27.3 Inflammatix Product and Services
2.27.4 Inflammatix PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
2.28 Helvoet
2.28.1 Helvoet Details
2.28.2 Helvoet Major Business
2.28.3 Helvoet Product and Services
2.28.4 Helvoet PCR-based Enteric Disease Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global PCR-based Enteric Disease Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 PCR-based Enteric Disease Testing Players Market Share
3.2.2 Top 10 PCR-based Enteric Disease Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global PCR-based Enteric Disease Testing Revenue and Market Share by Regions
4.2 North America PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
4.3 Europe PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
4.5 South America PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
5 North America PCR-based Enteric Disease Testing Revenue by Countries
5.1 North America PCR-based Enteric Disease Testing Revenue by Countries (2015-2020)
5.2 USA PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
5.3 Canada PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
6 Europe PCR-based Enteric Disease Testing Revenue by Countries
6.1 Europe PCR-based Enteric Disease Testing Revenue by Countries (2015-2020)
6.2 Germany PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
6.3 UK PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
6.4 France PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
6.5 Russia PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
6.6 Italy PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific PCR-based Enteric Disease Testing Revenue by Countries
7.1 Asia-Pacific PCR-based Enteric Disease Testing Revenue by Countries (2015-2020)
7.2 China PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
7.3 Japan PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
7.4 Korea PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
7.5 India PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
8 South America PCR-based Enteric Disease Testing Revenue by Countries
8.1 South America PCR-based Enteric Disease Testing Revenue by Countries (2015-2020)
8.2 Brazil PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue PCR-based Enteric Disease Testing by Countries
9.1 Middle East & Africa PCR-based Enteric Disease Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
9.3 UAE PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global PCR-based Enteric Disease Testing Revenue and Market Share by Type (2015-2020)
10.2 Global PCR-based Enteric Disease Testing Market Forecast by Type (2019-2024)
10.3 Analyzers/Instruments Revenue Growth Rate (2015-2025)
10.4 Kits/Panels Revenue Growth Rate (2015-2025)
11 Global PCR-based Enteric Disease Testing Market Segment by Application
11.1 Global PCR-based Enteric Disease Testing Revenue Market Share by Application (2015-2020)
11.2 PCR-based Enteric Disease Testing Market Forecast by Application (2019-2024)
11.3 Clostridium Difficile Revenue Growth (2015-2020)
11.4 Campylobacteriosis Revenue Growth (2015-2020)
11.5 Cholera Revenue Growth (2015-2020)
11.6 E. coli Infection Revenue Growth (2015-2020)
11.7 H. pylori Infection Revenue Growth (2015-2020)
11.8 Salmonellosis Revenue Growth (2015-2020)
11.9 Shigellosis Revenue Growth (2015-2020)
11.10 Rotavirus Infection Revenue Growth (2015-2020)
11.11 Norovirus Infection Revenue Growth (2015-2020)
11.12 Parasitic Enteric Disease Revenue Growth (2015-2020)
12 Global PCR-based Enteric Disease Testing Market Size Forecast (2021-2025)
12.1 Global PCR-based Enteric Disease Testing Market Size Forecast (2021-2025)
12.2 Global PCR-based Enteric Disease Testing Market Forecast by Regions (2021-2025)
12.3 North America PCR-based Enteric Disease Testing Revenue Market Forecast (2021-2025)
12.4 Europe PCR-based Enteric Disease Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific PCR-based Enteric Disease Testing Revenue Market Forecast (2021-2025)
12.6 South America PCR-based Enteric Disease Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa PCR-based Enteric Disease Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global PCR-based Enteric Disease Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of PCR-based Enteric Disease Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global PCR-based Enteric Disease Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market PCR-based Enteric Disease Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global PCR-based Enteric Disease Testing Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 7. Thermo Fisher Scientific PCR-based Enteric Disease Testing Major Business
Table 8. Thermo Fisher Scientific PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 9. Thermo Fisher Scientific SWOT Analysis
Table 10. Thermo Fisher Scientific PCR-based Enteric Disease Testing Product and Solutions
Table 11. Thermo Fisher Scientific PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Trinity Biotech Corporate Information, Location and Competitors
Table 13. Trinity Biotech PCR-based Enteric Disease Testing Major Business
Table 14. Trinity Biotech PCR-based Enteric Disease Testing Total Revenue (USD Million) (2018-2019)
Table 15. Trinity Biotech SWOT Analysis
Table 16. Trinity Biotech PCR-based Enteric Disease Testing Product and Solutions
Table 17. Trinity Biotech PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Meridian Life Science Corporate Information, Location and Competitors
Table 19. Meridian Life Science PCR-based Enteric Disease Testing Major Business
Table 20. Meridian Life Science PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 21. Meridian Life Science SWOT Analysis
Table 22. Meridian Life Science PCR-based Enteric Disease Testing Product and Solutions
Table 23. Meridian Life Science PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Vela Diagnostics Corporate Information, Location and Competitors
Table 25. Vela Diagnostics PCR-based Enteric Disease Testing Major Business
Table 26. Vela Diagnostics PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 27. Vela Diagnostics SWOT Analysis
Table 28. Vela Diagnostics PCR-based Enteric Disease Testing Product and Solutions
Table 29. Vela Diagnostics PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. bioMerieux SA Corporate Information, Location and Competitors
Table 31. bioMerieux SA PCR-based Enteric Disease Testing Major Business
Table 32. bioMerieux SA PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 33. bioMerieux SA SWOT Analysis
Table 34. bioMerieux SA PCR-based Enteric Disease Testing Product and Solutions
Table 35. bioMerieux SA PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. CorisBioconcept Corporate Information, Location and Competitors
Table 37. CorisBioconcept PCR-based Enteric Disease Testing Major Business
Table 38. CorisBioconcept PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 39. CorisBioconcept SWOT Analysis
Table 40. CorisBioconcept PCR-based Enteric Disease Testing Product and Solutions
Table 41. CorisBioconcept PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Etta Healthcare (Ovagene Oncology) Corporate Information, Location and Competitors
Table 43. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Major Business
Table 44. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 45. Etta Healthcare (Ovagene Oncology) SWOT Analysis
Table 46. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Product and Solutions
Table 47. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Abbott (ALERE) Corporate Information, Location and Competitors
Table 49. Abbott (ALERE) PCR-based Enteric Disease Testing Major Business
Table 50. Abbott (ALERE) PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 51. Abbott (ALERE) SWOT Analysis
Table 52. Abbott (ALERE) PCR-based Enteric Disease Testing Product and Solutions
Table 53. Abbott (ALERE) PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 55. Bio-Rad Laboratories PCR-based Enteric Disease Testing Major Business
Table 56. Bio-Rad Laboratories PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 57. Bio-Rad Laboratories SWOT Analysis
Table 58. Bio-Rad Laboratories PCR-based Enteric Disease Testing Product and Solutions
Table 59. Bio-Rad Laboratories PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. DiaSorin Molecular Corporate Information, Location and Competitors
Table 61. DiaSorin Molecular PCR-based Enteric Disease Testing Major Business
Table 62. DiaSorin Molecular PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 63. DiaSorin Molecular SWOT Analysis
Table 64. DiaSorin Molecular PCR-based Enteric Disease Testing Product and Solutions
Table 65. DiaSorin Molecular PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Fluxergy Corporate Information, Location and Competitors
Table 67. Fluxergy PCR-based Enteric Disease Testing Major Business
Table 68. Fluxergy PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 69. Fluxergy SWOT Analysis
Table 70. Fluxergy PCR-based Enteric Disease Testing Product and Solutions
Table 71. Fluxergy PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Genalyte Corporate Information, Location and Competitors
Table 73. Genalyte PCR-based Enteric Disease Testing Major Business
Table 74. Genalyte PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 75. Genalyte SWOT Analysis
Table 76. Genalyte PCR-based Enteric Disease Testing Product and Solutions
Table 77. Genalyte PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. ExcitePCR (PositiveID Corporation) Corporate Information, Location and Competitors
Table 79. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Major Business
Table 80. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 81. ExcitePCR (PositiveID Corporation) SWOT Analysis
Table 82. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Product and Solutions
Table 83. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. GenSpeed Biotech Corporate Information, Location and Competitors
Table 85. GenSpeed Biotech PCR-based Enteric Disease Testing Major Business
Table 86. GenSpeed Biotech PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 87. GenSpeed Biotech SWOT Analysis
Table 88. GenSpeed Biotech PCR-based Enteric Disease Testing Product and Solutions
Table 89. GenSpeed Biotech PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Focus Diagnostics (DiaSorin Molecular) Corporate Information, Location and Competitors
Table 91. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Major Business
Table 92. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 93. Focus Diagnostics (DiaSorin Molecular) SWOT Analysis
Table 94. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Product and Solutions
Table 95. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. FluimediX Corporate Information, Location and Competitors
Table 97. FluimediX PCR-based Enteric Disease Testing Major Business
Table 98. FluimediX PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 99. FluimediX SWOT Analysis
Table 100. FluimediX PCR-based Enteric Disease Testing Product and Solutions
Table 101. FluimediX PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Flow Alliance Corporate Information, Location and Competitors
Table 103. Flow Alliance PCR-based Enteric Disease Testing Major Business
Table 104. Flow Alliance PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 105. Flow Alliance SWOT Analysis
Table 106. Flow Alliance PCR-based Enteric Disease Testing Product and Solutions
Table 107. Flow Alliance PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. GeneFluidics PCR-based Enteric Disease Testing Type and Application
Table 109. GeneFluidics PCR-based Enteric Disease Testing Major Business
Table 110. GeneFluidics PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 111. GeneFluidics SWOT Analysis
Table 112. GeneFluidics PCR-based Enteric Disease Testing Product and Solutions
Table 113. GeneFluidics PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Future Horizon Scientific Corporate Information, Location and Competitors
Table 115. Future Horizon Scientific PCR-based Enteric Disease Testing Major Business
Table 116. Future Horizon Scientific PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 117. Future Horizon Scientific SWOT Analysis
Table 118. Future Horizon Scientific PCR-based Enteric Disease Testing Product and Solutions
Table 119. Future Horizon Scientific PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Fluid-Screen Corporate Information, Location and Competitors
Table 121. Fluid-Screen PCR-based Enteric Disease Testing Major Business
Table 122. Fluid-Screen PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 123. Fluid-Screen SWOT Analysis
Table 124. Fluid-Screen PCR-based Enteric Disease Testing Product and Solutions
Table 125. Fluid-Screen PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. iLine Microsystems Corporate Information, Location and Competitors
Table 127. iLine Microsystems PCR-based Enteric Disease Testing Major Business
Table 128. iLine Microsystems PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 129. iLine Microsystems SWOT Analysis
Table 130. iLine Microsystems PCR-based Enteric Disease Testing Product and Solutions
Table 131. iLine Microsystems PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 132. Gulf Bio Analytical Corporate Information, Location and Competitors
Table 133. Gulf Bio Analytical PCR-based Enteric Disease Testing Major Business
Table 134. Gulf Bio Analytical PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 135. Gulf Bio Analytical SWOT Analysis
Table 136. Gulf Bio Analytical PCR-based Enteric Disease Testing Product and Solutions
Table 137. Gulf Bio Analytical PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 138. IDEX Health&Science Corporate Information, Location and Competitors
Table 139. IDEX Health&Science PCR-based Enteric Disease Testing Major Business
Table 140. IDEX Health&Science PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 141. IDEX Health&Science SWOT Analysis
Table 142. IDEX Health&Science PCR-based Enteric Disease Testing Product and Solutions
Table 143. IDEX Health&Science PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 144. Danaher Corporate Information, Location and Competitors
Table 145. Danaher PCR-based Enteric Disease Testing Major Business
Table 146. Danaher PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 147. Danaher SWOT Analysis
Table 148. Danaher PCR-based Enteric Disease Testing Product and Solutions
Table 149. Danaher PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 150. HemoCue Corporate Information, Location and Competitors
Table 151. HemoCue PCR-based Enteric Disease Testing Major Business
Table 152. HemoCue PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 153. HemoCue SWOT Analysis
Table 154. HemoCue PCR-based Enteric Disease Testing Product and Solutions
Table 155. HemoCue PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 156. Hahn-Schickard Corporate Information, Location and Competitors
Table 157. Hahn-Schickard PCR-based Enteric Disease Testing Major Business
Table 158. Hahn-Schickard PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 159. Hahn-Schickard SWOT Analysis
Table 160. Hahn-Schickard PCR-based Enteric Disease Testing Product and Solutions
Table 161. Hahn-Schickard PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 162. Inflammatix Corporate Information, Location and Competitors
Table 163. Inflammatix PCR-based Enteric Disease Testing Major Business
Table 164. Inflammatix PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 165. Inflammatix SWOT Analysis
Table 166. Inflammatix PCR-based Enteric Disease Testing Product and Solutions
Table 167. Inflammatix PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 168. Helvoet Corporate Information, Location and Competitors
Table 169. Helvoet PCR-based Enteric Disease Testing Major Business
Table 170. Helvoet PCR-based Enteric Disease Testing Total Revenue (USD Million) (2017-2018)
Table 171. Helvoet SWOT Analysis
Table 172. Helvoet PCR-based Enteric Disease Testing Product and Solutions
Table 173. Helvoet PCR-based Enteric Disease Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 174. Global PCR-based Enteric Disease Testing Revenue (Million USD) by Players (2015-2020)
Table 175. Global PCR-based Enteric Disease Testing Revenue Share by Players (2015-2020)
Table 176. Global PCR-based Enteric Disease Testing Revenue (Million USD) by Regions (2015-2020)
Table 177. Global PCR-based Enteric Disease Testing Revenue Market Share by Regions (2015-2020)
Table 178. North America PCR-based Enteric Disease Testing Revenue by Countries (2015-2020)
Table 179. North America PCR-based Enteric Disease Testing Revenue Market Share by Countries (2015-2020)
Table 180. Europe PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2015-2020)
Table 181. Asia-Pacific PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2015-2020)
Table 182. South America PCR-based Enteric Disease Testing Revenue by Countries (2015-2020)
Table 183. South America PCR-based Enteric Disease Testing Revenue Market Share by Countries (2015-2020)
Table 184. Middle East and Africa PCR-based Enteric Disease Testing Revenue (Million USD) by Countries (2015-2020)
Table 185. Middle East and Africa PCR-based Enteric Disease Testing Revenue Market Share by Countries (2015-2020)
Table 186. Global PCR-based Enteric Disease Testing Revenue (Million USD) by Type (2015-2020)
Table 187. Global PCR-based Enteric Disease Testing Revenue Share by Type (2015-2020)
Table 188. Global PCR-based Enteric Disease Testing Revenue Forecast by Type (2021-2025)
Table 189. Global PCR-based Enteric Disease Testing Revenue by Application (2015-2020)
Table 190. Global PCR-based Enteric Disease Testing Revenue Share by Application (2015-2020)
Table 191. Global PCR-based Enteric Disease Testing Revenue Forecast by Application (2021-2025)
Table 192. Global PCR-based Enteric Disease Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. PCR-based Enteric Disease Testing Picture
Figure 2. Global PCR-based Enteric Disease Testing Revenue Market Share by Type in 2019
Figure 3. Analyzers/Instruments Picture
Figure 4. Kits/Panels Picture
Figure 5. PCR-based Enteric Disease Testing Revenue Market Share by Application in 2019
Figure 6. Clostridium Difficile Picture
Figure 7. Campylobacteriosis Picture
Figure 8. Cholera Picture
Figure 9. E. coli Infection Picture
Figure 10. H. pylori Infection Picture
Figure 11. Salmonellosis Picture
Figure 12. Shigellosis Picture
Figure 13. Rotavirus Infection Picture
Figure 14. Norovirus Infection Picture
Figure 15. Global PCR-based Enteric Disease Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global PCR-based Enteric Disease Testing Revenue Share by Players in 2019
Figure 23. Global Top 5 Players PCR-based Enteric Disease Testing Revenue Market Share in 2019
Figure 24. Global Top 10 Players PCR-based Enteric Disease Testing Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global PCR-based Enteric Disease Testing Revenue Market Share by Regions (2015-2020)
Figure 28. Global PCR-based Enteric Disease Testing Revenue Market Share by Regions in 2018
Figure 29. North America PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 30. Europe PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 32. South America PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 34. North America PCR-based Enteric Disease Testing Revenue Market Share by Countries (2015-2020)
Figure 35. North America PCR-based Enteric Disease Testing Revenue Market Share by Countries in 2019
Figure 36. USA PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 37. Canada PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 38. Mexico PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 39. Europe PCR-based Enteric Disease Testing Revenue Market Share by Countries (2015-2020)
Figure 40. Europe PCR-based Enteric Disease Testing Revenue Market Share by Countries in 2019
Figure 41. Germany PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 42. UK PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 43. France PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 44. Russia PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 45. Italy PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific PCR-based Enteric Disease Testing Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific PCR-based Enteric Disease Testing Revenue Market Share by Countries in 2019
Figure 48. China PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 49. Japan PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 50. Korea PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 51. India PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 53. South America PCR-based Enteric Disease Testing Revenue Market Share by Countries (2015-2020)
Figure 54. South America PCR-based Enteric Disease Testing Revenue Market Share by Countries in 2019
Figure 55. Brazil PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 56. Argentina PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa PCR-based Enteric Disease Testing Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa PCR-based Enteric Disease Testing Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 60. UAE PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 61. Egypt PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 62. South Africa PCR-based Enteric Disease Testing Revenue and Growth Rate (2015-2020)
Figure 63. Global PCR-based Enteric Disease Testing Revenue Share by Type (2015-2020)
Figure 64. Global PCR-based Enteric Disease Testing Revenue Share by Type in 2019
Figure 65. Global PCR-based Enteric Disease Testing Market Share Forecast by Type (2021-2025)
Figure 66. Global Analyzers/Instruments Revenue Growth Rate (2015-2020)
Figure 67. Global Kits/Panels Revenue Growth Rate (2015-2020)
Figure 68. Global PCR-based Enteric Disease Testing Revenue Share by Application (2015-2020)
Figure 69. Global PCR-based Enteric Disease Testing Revenue Share by Application in 2019
Figure 70. Global PCR-based Enteric Disease Testing Market Share Forecast by Application (2021-2025)
Figure 71. Global Clostridium Difficile Revenue Growth Rate (2015-2020)
Figure 72. Global Campylobacteriosis Revenue Growth Rate (2015-2020)
Figure 73. Global Cholera Revenue Growth Rate (2015-2020)
Figure 74. Global E. coli Infection Revenue Growth Rate (2015-2020)
Figure 75. Global H. pylori Infection Revenue Growth Rate (2015-2020)
Figure 76. Global Salmonellosis Revenue Growth Rate (2015-2020)
Figure 77. Global Shigellosis Revenue Growth Rate (2015-2020)
Figure 78. Global Rotavirus Infection Revenue Growth Rate (2015-2020)
Figure 79. Global Norovirus Infection Revenue Growth Rate (2015-2020)
Figure 80. Global Parasitic Enteric Disease Revenue Growth Rate (2015-2020)
Figure 81. Global PCR-based Enteric Disease Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 82. Global PCR-based Enteric Disease Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 83. Global PCR-based Enteric Disease Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 84. North America PCR-based Enteric Disease Testing Revenue Market Forecast (2021-2025)
Figure 85. Europe PCR-based Enteric Disease Testing Revenue Market Forecast (2021-2025)
Figure 86. Asia-Pacific PCR-based Enteric Disease Testing Revenue Market Forecast (2021-2025)
Figure 87. South America PCR-based Enteric Disease Testing Revenue Market Forecast (2021-2025)
Figure 88. Middle East and Africa PCR-based Enteric Disease Testing Revenue Market Forecast (2021-2025)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
腸疾患検査・治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Enteric Disease Testing and Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.4% in the forecast period of 2020 to 2025 and will expected to reach USD 3273.4 million by 2025, from USD 3101.6 million in 2019. …- 感染症迅速診断検査キットの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Infectious Disease Rapid Diagnostic Testing Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players…
- 希少疾患遺伝子検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Rare Disease Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- PCR検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The PCR-Based Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 腸溶性ソフトジェルカプセルの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Enteric Softgel Capsules market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1872.2 million by 2025, from USD 1710.8 million in 2019. The Enteric Sof…